Showing results (361-370 of 395) with videos related to

Sort By:
Pageof 40
International Journal of Cancer|May 8, 2000
Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptidesE Jäger, M Maeurer, H Höhn, et al.
Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.
The Journal of Experimental Medicine|February 7, 1998
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopesE Jäger, Y T Chen, J W Drijfhout, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytesD Runge, C Köhler, V E Kostrubsky, et al.
Experimental Hematology|January 3, 2007
Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in ratsMark D Jäger, Jian Y Liu, Kai F Timrott, et al.
Zeitschrift Fur Gastroenterologie|May 13, 2016
[Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer]E Czink, C Heining, T F Weber, et al.
Clinical Genitourinary Cancer|December 3, 2014
Sorafenib treatment of advanced renal cell carcinoma patients in daily practice: the large international PREDICT studyD Jäger, J H Ma, J Mardiak, et al.
Biochemical and Biophysical Research Communications|March 1, 2000
Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functionsD Runge, D M Runge, D Jäger, et al.
Cancer Immunity|May 16, 2003
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expressionM J Scanlan, I Gout, C M Gordon, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trialR Stelmach, S Lorenzen, T J Ettrich, et al.
Pageof 40